Cold drug debate could take years to shake out
Drugmakers promise to fight restrictions on use in older kids
Kids and parenting videos |
Too old to give birth? July 16: World’s oldest woman to give birth dies, leaving twin toddlers. NBC’s Dr. Nancy Snyderman talks with fertility specialist Dr. Nicole Noyes about whether stricter limits on fertility treatments are needed. |
Most popular |
| |||||
It brought widespread shock and disbelief.
Parents across the country heard last week that there is no evidence that widely used over-the-counter medications do any good for common cold symptoms in children. A Food and Drug Administration panel of experts said that the drugs shouldn't be given to children under 6.
Blogs lit up with parents flatly declaring that taking away these products would amount to government intrusion into their common sense. But parents should relax. Nothing will change for years, if ever.
The surprise is understandable. According to the New York Times, there are about 800 cough and cold preparations for children available in the United States. Parents spend almost $500 million on some 95 million boxes that they use to dispense 3.8 billion doses a year. In one month alone, fully one-third of all the 3-year-olds in the country got at least one dose of a cough or cold medicine, a 1994 study found.
Heavy marketing
How could this be if the drugs are no good?
Industry representatives raised that point many times during the two days of FDA panel hearings. “If these medicines are allegedly not effective or materially unsafe, how is the purchase of hundreds of millions of doses explained?” asked panel member Dr. George Goldstein, a pharmaceutical industry consultant.
“It is marketing,” replied Dr. Richard Neill, a family medicine physician with the University of Pennsylvania Health System. During the hearings panel members saw numerous examples of packaging and ads for the medicines, all picturing happy infants and toddlers.
Heavy marketing is certainly a big factor in the use of these medicines — as it is with many other over-the-counter drugs.
But this issue also has a long history. Most of the ingredients in cough and cold medicines, for both children and adults, have been around for decades — so long that they did not have to meet the standards that would apply for a drug coming to market today.
'Not little adults'
|
When it came to treating children, two prevailing views dominated the thinking of pediatricians and pharmacologists at that time and into the ‘70s. First, if a drug worked in adults, it was fine to give it to children at lower doses. The usual formula was: half a dose for children ages 6 to 12; a quarter for those 2 to 6; and an eighth for those under 2. A second view held it was unethical to perform experiments on children.
Since then, the conventional wisdom has shifted 180 degrees. At last week’s hearings, it was often heard that “children are not little adults.” Kids often metabolize drugs differently from adults and show different reactions. Experts now believe that, with proper safeguards, studies can and should be carried out on children.
The problem is not that large, well-conducted studies show the drugs fail to work in children. The issue is a lack of evidence one way or the other. As a result, the panel asked the FDA to compel companies to set up studies to find the answers.
The panel came very close to recommending that the medications not be used in kids under 12 based on the the lack of proof that they work, combined with the clear evidence that — in rare cases — the medications can cause serious side effects, even an occasional death. Dr. Robert Daum, pediatric infectious disease specialist at the University of Chicago, said, "If there is no evidence of efficacy, I can't support the use of” the medicines in children.
- Discuss Story On Newsvine
-
Rate Story:
View popularLowHigh - Instant Message
MORE FROM KIDS AND PARENTING |
| Add Kids and parenting headlines to your news reader: |
Resource guide



